Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)
Clinical trial NCT04629144 · UNKNOWN
Trial details
- NCT number
- NCT04629144
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2025-04-20
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.